Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1 3Phase 1/2 2Phase EARLY_PHASE1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Ovarian Neoplasms 5Pancreatic Neoplasms 2Glioblastoma 2Breast Neoplasms 2Sarcoma 1Recurrence 1Prostatic Neoplasms 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1

Interventions

Cyclophosphamide 7fludarabine 4Dasatinib 2zimberelimab 1pembrolizumab 1palbociclib 1olaparib 1fluorodopa F 18 1Vincristine 1Vemurafenib 1Topotecan 1Temozolomide 1Sirolimus 1Peripheral Blood Stem Cell Transplantation 1Methotrexate 1Magnetic Resonance Spectroscopy 1Influenza Vaccines 1Fluoxetine 1Fluorodeoxyglucose F18 1Everolimus 1Etoposide 1Doxorubicin 1Decitabine 1Cholestanetriol 26-Monooxygenase 1CVAD protocol 1Busulfan 1Afatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Recurrence × olaparib × Clear all
NCT05432518 2025-04-25

Pilot Trial for Treatment of Recurrent Glioblastoma

AHS Cancer Control Alberta

Phase EARLY_PHASE1 Recruiting
10 enrolled
CNS

Glioblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡